Pain Management Devices Market: Historical Size and Share Analysis, Future Growth Potential, Key Regions, Forecast till 2030

Market Overview

The size of the pain management devices market size has been estimated at USD 2,518.2 million in 2023, and is will power at a CAGR of 9.6% between 2023 and 2030, to reach USD 4,792.2 million by 2030. The increasing occurrence of chronic conditions is a major contributor to the growth of the industry, as lifestyle-related diseases, for example, obesity and diabetes, propel the requirement for nerve and muscle stimulators. Other health issues that can cause pain are hypertension or trauma.

The growing surgery count all over the globe is another key driver for the industry. The increasing incidence of neurological disorders, CVDs, and cancer has boosted the demand for surgical interventions, which has, in turn, made pain management devices necessary.

Moreover, technological progressions and the introduction of minimally invasive analgesic procedures drive the market. Furthermore, the growing emphasis on the early detection and treatment of diseases and the booming government initiatives to enhance the outcomes for patients with chronic pain also support in this regard.

Growing Incidence of Chronic Diseases Is Key Market Driver

The major driver for the market is the increasing number of people with chronic diseases, many of which have pain as the foremost symptom. For instance, hypertension substantially increases the risk of brain aneurysms, which, if ruptured, cause agonizing pain. According to the WHO’s data released in March 2023, about 1.28 billion adults aged 30 to 79 years have hypertension.

Furthermore, the incidence of musculoskeletal ailments, such as orthopedic degenerative diseases, osteoarthritis, and rheumatoid arthritis, is on the rise. This has augmented the incidence of chronic pain and the inability to perform everyday chores. As per the CDC, more than 58.5 million adults in the U.S. are suffering from arthritis. It further expects about 35 million individuals to face issues in their usual activities owing to this condition by 2040.

Increasing Cases of Phantom Limb Pain Associated with Amputations

The increasing count of amputation surgeries is also a key reason for the rising demand for pain management devices. A number of reasons can result in amputations, such as musculoskeletal conditions, flesh-eating diseases, accidents, sports injuries, vascular diseases, violence (due to battles), diabetes, and genetic factors. An amputation is majorly done when either the injury is too complicated to be repaired and risks damage to the surrounding tissue or to stop the spread of diseases, such as cancer, gangrene, and necrotizing fasciitis.

As per reports, over 1 million amputations are carried out every year. The wound created by such surgeries can take up to 6 months to heal, causing significant pain during the time. Additionally, phantom limb, wherein the brain senses pain in the limb even though it is not there anymore, drives the requirement for chronic pain management devices. As per Cleveland Clinic, 8 in 10 people who have had a limb amputated experience phantom limb pain.

Explore more about this report - Request free sample pages

North America Is Biggest Market

North America is leading the industry because of the easy availability of cutting-edge healthcare technologies and the growing usage of pain management devices in ambulatory centers. As per the Journal of Pain and Palliative Therapy, over 20% of the population of the U.S. is suffering from chronic pain and 5% of the adults suffer from high-impact chronic pain.

Additionally, because of the high incidence of neuropathic pain in the U.S., people are more dependent on pain management devices than medicines. As per an article in the journal Pain Medicine, around 2% of the people in the U.S. suffer from neuropathic pain. Thus, since over half the country’s population has at least one chronic condition and accompanying pain, the market continues to advance in the region.

APAC will grow at a significant rate in the next seven years mainly because of the R&D investments in the pain management area. Additionally, a surge in the consciousness of implantable pain management devices drives their acceptance by the people in the region. The developments in the healthcare infrastructure, increase in the count of hospitals, and increase in the geriatric population will help in the growth of the industry in the region.

The increasing focus of prominent manufacturers on improving their presence in the emerging economies in the region, by making the most of a large patient base, and the increasing income are some of the factors powering the regional market growth.

Demand for Cancer Pain Management Devices To Grow Fastest

The neuropathic pain category has the largest revenue share, credited to the increasing count of initiatives by the key players to help people manage neuropathic pain better. Additionally, studies have linked an increased severity of neuropathic pain in people with COVID-19. This could be due to the emergence of comorbidities, such as Guillain–Barré syndrome, stroke, and myelitis. Other common causes of neuropathic pain are MS, postherpetic neuralgia, diabetic peripheral neuropathy, and spinal cord injury.

The cancer pain category of the application segment will have the fastest growth in the next seven years. The surging cancer patient count has increased the requirement for pain management devices to relieve the pain from nerve compression by tumors. Further, pain is among the most-noticeable symptoms of bone cancer. As per the Indian Journal of Medical Research in November 2022, 1,461,427 cancer cases were discovered in India in 2022, and about 1 in 9 individuals are at a risk of it.

Neurostimulation Products Are Used Most

Neurostimulation products had the largest revenue share in the past, because of the increase in the incidence of neurological diseases. Neurostimulators play an important role in the management of chronic pain due to Parkinson’s, apart from epilepsy, movement-related ailments, and depression. In this regard, the introduction of advanced products and growing elderly population will power the industry.

For instance, as per the Government of the U.K., the populace falling under the age group of 60 and above was 14.5 million in 2021. The rising aging populace will increase the sale of pain management products as the elderly possess a higher risk of a chronic diseases and physical injuries.

The radiofrequency ablation category will grow the fastest till the end of this decade because of the rising usage of this approach in the treatment of pain associated with arthritis, neurological conditions, cancer, back pain, and .. RF ablation destroys the nerve fibers in the diseased areas that convey pain signals to the brain, thus easing the sensation.

Who Are Key Players in Pain Management Devices Market?

• Medtronic plc
• Abbott Laboratories
• Stryker Corporation
• B. Braun Melsungen AG
• Boston Scientific Corp.
• Baxter International Inc.
• OMRON Healthcare Inc.
• Smith & Nephew plc
• Kimberly-Clark Corporation
• DJO Global LLC
• Pfizer Inc.
• Johnson and Johnson Services Inc.
• Becton, Dickinson and Company
• Nevro Corp.
• NeuroSpine LLC
• SPR Therapeutics